Tpst stock analysis
Splet10. apr. 2024 · The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section. ... (TPST) stock has risen 9.88% while the S&P 500 is lower by -0.11% as of 3:30 … SpletView the latest Tempest Therapeutics Inc. (TPST) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Tpst stock analysis
Did you know?
SpletIts TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study agents as monotherapies and in combination with other approved agents. The company … SpletTempest Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Tempest Therapeutics historical stock prices and determine the direction of Tempest Therapeutics's future trends based on various well-known forecasting models.
SpletSOUTH SAN FRANCISCO, Calif., March 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing... SpletThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price …
Splet13. apr. 2024 · Technical Analysis; Trading Tips; Stock Scanners; Trading Psychology; ... IMBI, ALPS, TPST, CYXT, MYSZ, WETG. Market internals (TOTAL) 9,118 Advancers 4,138 Decliners. Market internals (OTC) 2,486 Advancers ... One such approach is trading low-float stocks. Low float stocks are a type of stock with a limited number of shares available for ... SpletTPST Complete Tempest Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
SpletAnalysts Offer Insights on Healthcare Companies: Tempest Therapeutics (TPST), Kiora Pharmaceuticals (KPRX) and Indaptus Therapeutics (INDP) InvestorPlace 68d Today’s …
SpletIs Tempest Therapeutics Stock Undervalued? The current Tempest Therapeutics share price is $1.84. The Score for TPST is 44, which is 12% below its historic median score of … bone marrow for weight lossSplet10. mar. 2024 · A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a stock,... bone marrow fruit snacksSpletTPST chart Today 4.01% Week 1.25% 1 month 62.00% 6 months 38.44% Year to date 104.20% 1 year −37.69% 5 years −98.62% All time −99.86% Key stats Market capitalization 25.665M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −3.50 USD About Tempest Therapeutics, Inc ISIN US87978U1088 Sector Health … goat themed baby showerSpletTempest Therapeutics Debt to Equity Ratio is comparatively stable at the moment as compared to the past year. Tempest Therapeutics reported Debt to Equity Ratio of 0.38 in 2024. Sales per Share is likely to gain to 2.81 in 2024, whereas Revenue to Assets are likely to drop 0.003515 in 2024. bone marrow forkSpletTempest Therapeutics, Inc. (TPST) Stock Price, News, Quote & History - Yahoo Finance (-0.38%) -114.75(-0.87%) -9.70 Tempest Therapeutics, Inc. (TPST) NasdaqCM - NasdaqCM … bone marrow for soupSpletThe average Tempest Therapeutics stock price prediction forecasts a potential upside of 743.62% from the current TPST share price of $2.43. What is TPST's forecast return on … bone marrow graft rejectionSplet14. mar. 2024 · Company Profile TPST Business Description Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat … goat themed fabric